Fund manager Templeton Asset Management has announced the conclusion of all remaining investments formerly being held at the Templeton Strategic Emerging Markets Fund.

The fund focused on China, India and the former Soviet Union and had been established in 2000 by Mark Mobius. Having reached maturity, it has recently been concentrating on finding attractive exits. The final tally for the $110 million fund is a 24.4% gross internal rate of return, and a return after performance fees of 19.8%.

The fundÆs total disbursements amounted to $246 million, equating to a multiple of 2.2 times initial capital.

Some of the fundÆs highlight investments include Aurobindo Pharmaceutical, a Mumbai-based drug maker on which the fund quadrupled its $11 million investment, and Yaolan, otherwise known as æBabycareÆ which is a mainland Chinese manufacturer of baby food.

A spokesperson from Templeton says MobiusÆ emerging-markets fund team members remain in their seats and are currently handling other Templeton assets. The group currently manages $33 billion.